BNCWZ CEA Industries, Inc. Management crisis
Free read

CEA Industries CEO Namdar Out; CFO Holds Three Titles at Once

At edition (Jul 24, 2026) $118M

David Namdar's tenure as CEO of CEA Industries (BNC) formally ended July 22, when the board appointed CFO William B. Miller to simultaneously serve as Interim Principal Executive Officer — with no additional pay. Day-to-day operations fall to Alex Odagiu, a board member engaged through a consulting firm at $25,000 per month for 32 hours a week. The company enters this leadership gap with $3.1 million in cash at fiscal year-end, 515,544 BNB tokens worth $319.6 million on its balance sheet, an active lawsuit seeking to void its 20-year asset management agreement, and a pending EPS restatement covering two quarterly periods.

NWBI Northwest Bancshares, Inc. Exec Pay Governance

Northwest Bancshares CEO Awarded 125,298 RSUs Bundling Rescinded Grant and Two Missed Annual Awards

At edition (Jul 24, 2026) $2.2B · Live $2.3B

Northwest Bancshares approved 125,298 restricted stock units for CEO Lou Torchio on July 22, 2026, covering three components: the portion of a December 2024 grant that was rescinded after it was found to exceed the 2022 equity plan's $1,000,000 individual limit, plus regular annual grants the board expected to make in March 2025 and March 2026 that were not made because the old limit was in place. Shareholders voted at the May 20, 2026 annual meeting to raise the per-person cap to $5,000,000 under a new 2026 plan. The new award vests four years from its grant date, effective on or about July 31, 2026.

IVVD Invivyd, Inc. Distressed

Invivyd Gets Second Nasdaq Warning Amid FDA Product Termination

At edition (Jul 24, 2026) $179M · Live $180M

Invivyd received its second Nasdaq minimum bid price deficiency notice in 15 months on July 23, 2026, giving it until January 19, 2027 to push its stock back above $1.00. The notice came 17 days after the FDA sent a 12-month advance termination notice for the EUA on PEMGARDA — the company's sole commercial product and only source of revenue. A company that raised over $170 million in two equity offerings in the second half of 2025 is now back in Nasdaq compliance trouble with its revenue base facing a known expiration date.

GPRO Gopro, Inc. Distressed

GoPro Receives Second Nasdaq Minimum Bid Warning in 16 Months

At edition (Jul 24, 2026) $119M · Live $116M

GoPro's Class A shares have traded below $1.00 for 30 consecutive business days, triggering a second Nasdaq deficiency notice in 16 months and a new 180-day compliance clock. The company had cured an identical notice — first received March 25, 2025 — by August 5, 2025, only to fall back below the threshold. The second notice arrives as GoPro runs a Houlihan Lokey-led sale process, carries negative stockholders' equity, and faces a separate lender-imposed deadline to consummate a refinancing or sale by approximately January 5, 2027. CEO Nicholas Woodman provided $20 million in emergency financing on July 9, 2026, secured by a third lien on substantially all company assets.

ELME ELME Communities Wind Down

Elme Cuts Distribution Estimate as Riverside Apartments Sells at $30M Discount

At edition (Jul 24, 2026) $131M · Live $132M

Elme Communities signed a new agreement to sell its largest remaining property, Riverside Apartments, for $250 million — $30 million less than the prior contract terminated June 17. Total estimated liquidating distributions were cut to $16.41–$16.61 per share, down from $16.74–$17.02 in May and from $17.40–$18.32 at the time shareholders approved the wind-down in October 2025. The new Riverside deal remains in an inspection period through August 20, 2026, leaving it terminable by the buyer without penalty until that date.

CHGG CHEGG, Inc. Distressed

Chegg Gets Second NYSE Delisting Notice in Seven Months

At edition (Jul 24, 2026) $109M · Live $108M

Chegg received a second NYSE price-compliance notice on July 24, 2026 — less than two months after curing an identical deficiency that originated in December 2025. The company has a six-month window to restore its average closing price above $1.00, and a reverse stock split can now be executed by the board alone, shareholder approval having already been secured at the June 12, 2026 annual meeting. The relapse adds to a string of distress signals at the approximately $108.9 million market cap company, including a 45% workforce reduction, a CEO change, an auditor switch from Deloitte to Grant Thornton, and $33.9 million in convertible notes maturing in 2026.

LEE LEE Enterprises, Inc. Controlling Shareholder

Lee Loosens Share Accumulation Cap for Its Majority Shareholder

At edition (Jul 24, 2026) $169M · Live $166M

Lee Enterprises amended the standstill provisions in its December 2025 Stock Purchase Agreement on July 24, 2026, allowing investors who already own more than 10% of the company's shares to purchase beyond the previous 600,000-share open-market cap — provided additional purchases go through a company-approved Rule 10b5-1 trading plan. The amendment benefits the same investor group led by David Hoffmann, who holds approximately 52% of Lee's outstanding stock, chairs its board, and whose affiliated entity, Hoffmann Media Group, began receiving $135,000 per quarter from Lee under a five-year management agreement that took effect June 1, 2026. The standstill loosening adds one more degree of freedom to a position that is already a controlling interest.

DOCN Digitalocean Holdings, Inc. Serial Equity Issuance

DigitalOcean Issues $1.47B in Stock to Buy Back In-the-Money Converts

At edition (Jul 24, 2026) $15.3B · Live $14.4B

DigitalOcean sold 12.54 million shares at $117.54 each on July 23, 2026, raising approximately $1.474 billion, then used those proceeds to retire $471.8 million face value of its 0.00% Convertible Senior Notes due 2030 at roughly 3.1x par — a price that reflects the notes' deep in-the-money status, not a windfall to departing holders. It is the company's second equity offering in four months, the two together totaling more than $2.3 billion in gross proceeds, executed against a backdrop of accelerating AI-driven revenue growth and a stock that has risen 58% since the March transaction.

BXSL Blackstone Secured Lending Fund Management crisis

BXSL Loses Co-CEO and COO Within 35 Days, No Successors Named

At edition (Jul 24, 2026) $5.4B · Live $5.4B

Jonathan Bock resigned as Co-Chief Executive Officer of Blackstone Secured Lending Fund on July 20, 2026, 35 days after COO Katherine Rubenstein left the same vehicle. Neither departure named a replacement, and both filings carried identical boilerplate language stating the exits were unrelated to any disagreement with Blackstone or the Fund's operations. Brad Marshall remains as the sole Co-CEO of the $5.4 billion BDC, which entered 2026 with rising portfolio non-accruals and a declining net asset value per share.

LAB Standard Biotools, Inc. Merger Pending

Standard BioTools Gets Second Nasdaq Bid-Price Warning With Merger Pending

At edition (Jul 24, 2026) $343M · Live $326M

Standard BioTools received its second Nasdaq minimum bid-price deficiency notice of 2026 on July 22, with its stock having closed below $1.00 for 30 consecutive business days — a relapse that came less than seven weeks after it cured the first notice on June 5. The company has until January 19, 2027 to regain compliance, and its pending all-stock merger with Treeline Biosciences — which values Standard BioTools at $460 million and requires continued Nasdaq listing as a closing condition — explicitly contemplates a reverse stock split to address the share price. Whether the deal closes before the deadline matters more than the notice itself.

ONCY Oncolytics Biotech, Inc. Distressed

Oncolytics Receives Nasdaq Deficiency Notice After Stock Falls Below $1

At edition (Jul 24, 2026) $101M · Live $97M

Oncolytics Biotech received a Nasdaq minimum bid price deficiency notice on July 20, 2026, after its common stock closed below $1.00 for 30 consecutive business days. The company has until January 19, 2027 to cure the breach, with a potential second 180-day window if it meets other listing conditions. The notice lands against documented financial stress: Ernst & Young's audit reports for both fiscal 2024 and fiscal 2025 contained going-concern explanatory paragraphs, and the company opened a $75 million at-the-market equity facility in April. On the same day the notice arrived, the FDA granted pelareorep a Fast Track Designation in anal carcinoma.

BCO Brinks Co. Accounting Change

Brink's Removes Malaysia Unit From Consolidated Financials, Cutting $100M in Revenue

At edition (Jul 24, 2026) $5.0B · Live $5.0B

Brink's will stop consolidating its Malaysia business after an unspecified change in the company's involvement there, reducing reported revenue by approximately $100 million and adjusted EBITDA by $10 million to $15 million over the next four quarters. Management says the change has no effect on its full-year 2026 organic growth and margin expansion framework, which excludes the effects of dispositions. The disclosure was made while Q2 2026 financial close procedures were still underway, and the company did not specify what triggered the shift in its Malaysian operations.

CPAY Corpay, Inc. Executive Pay Controversy

Corpay Grants CEO 300,000 PSUs After 44% Say-on-Pay Opposition

At edition (Jul 24, 2026) $23.8B · Live $24.2B

Corpay's Compensation Committee approved a special grant of 300,000 performance-based stock units to CEO Ronald Clarke on July 22, 2026, with stock price hurdles of $425, $450, and $475 per share through August 2028. The grant came 76 days after Corpay's annual meeting, where roughly 44% of shares voted against the company's executive pay program on an advisory basis — a level of dissent that typically prompts boards to moderate, not expand, executive awards. A concurrent grant of 28,213 PSUs was made to executive Armando Netto. If all three price tranches vest, the Clarke award would deliver 300,000 units at prices between $425 and $475 per share.

QSI Quantum-Si, Inc. Distressed

Quantum-Si Stock Falls Below $1, Triggering Nasdaq Compliance Clock

At edition (Jul 24, 2026) $172M · Live $168M

Nasdaq notified Quantum-Si on July 23, 2026 that its Class A shares have closed below $1.00 for 30 consecutive business days, violating the minimum bid price rule and starting a 180-day compliance clock that expires January 19, 2027. The company burned $101.3 million in 2025 on $2.4 million in revenue and has guided 2026 revenue lower still at approximately $1.0 million, with projected cash usage of up to $93 million. The $190.4 million in cash and marketable securities held as of March 31, 2026 gives management-stated runway into the second quarter of 2028. Just 35 days before the notice, Quantum-Si signed a 120-month, 54,374-square-foot lease in San Diego — though initial rent payments are abated for 20 months from an anticipated September 2027 commencement date.